Blick TV Launches Switzerland’s First Digital TV Channel, Powered by Brightcove
Brightcove Inc. (NASDAQ: BCOV), the world’s leading video technology platform, today announced that Switzerland’s first 24/7 digital TV channel, Blick TV, is running on Brightcove Live™ and Video Cloud. The newly launched TV channel – which falls under media group Ringier – offers viewers both a live and video on-demand viewing experience online at Blick.ch, as well as in the Blick app for mobile devices (iOS and Android). Blick TV is a significant milestone for Ringier as the media group has invested significant resources into digital streaming including two news studios, as well as a core team of 48 reporters, editorial staff, and hosts to report on news stories daily. Blick TV brings its audiences live breaking national news stories, as well as capitalizes on its partnership with CNN to bring audiences international news stories.
As one of the largest media brands in Switzerland, reaching more than 1.5 million people daily, the Blick Group leveraged Brightcove’s video platform to adopt a mobile-first digital strategy that is capable of delivering a high-quality video experience, as well as allow its audiences to watch content on their device of choice. The launch of Blick TV highlights the importance for media companies to move towards a mobile-first, video-driven content strategy given the major shift in the way people prefer to consume content.
Using Brightcove, Blick TV live streams breaking news topics for its viewers, as well as easily creates segmented clips to store for seamless video on-demand viewing. There are also some notable features of Blick TV that highlight its competitive advantage, including:
- Video Subtitles: Styled and positioned in the video player, an interpreter repeats the content in standard German, which is then converted to text with an opportunity to edit. Enabling smartphone use on-the-go as well as barrier-free access, subtitles are a critical component of the viewing experience and make video accessible to all audiences.
- Portrait and Landscape Viewing: Optimized for mobile viewership, viewers are offered both portrait and landscape viewing, without the quality being compromised if it is recorded in one format and viewed in another. In portrait mode, only the central portion of the video is visible, and is the same stream resized, instead of a separate live stream. Additionally, the subtitles, Blick TV logo, and headlines are customized and positioned differently based on portrait and landscape.
“When we decided to launch Switzerland’s first digital TV station we knew how crucial a superior user experience would be,” said Thomas Spiegel, CEO, Blick Group. “With the ability to offer subtitles, as well as both portrait and landscape viewing, we are not only giving our users a premium experience, but giving ourselves a long-term competitive advantage. We attribute these breakthroughs to Brightcove’s feature-rich video platform. Since launching Blick TV, we’ve been able to increase video on-demand content, cater to all viewing preferences, and become the go-to 24/7 digital TV channel for audiences who want to view live and on-demand video content.”
“By choosing a scalable, reliable platform like Brightcove Live, Blick TV is able to achieve Ringier’s three key pillars of success: informing, entertaining, and connecting with its audiences,” said Justin Barrett, Vice President, EMEA, Brightcove. “We are thrilled that Ringier chose Brightcove to power Switzerland’s first ever digital news channel, and excited our video services are being expanded to more audiences globally.”
Ringier AG is an innovative, digitalized and diversified Swiss media company active in Europe, Africa and Asia. The portfolio includes over 100 subsidiaries in the areas of print, digital media, radio, ticketing, entertainment and e-commerce as well as leading digital marketplaces in the areas of automobiles, real estate and jobs. As a venture capitalist, Ringier promotes innovative digital start-ups. Founded in 1833 as a publishing house and printing house, Ringier is a family-owned company that has consistently invested in the digitalization and internationalization of the Group in recent years. In 2018, around 7300 employees in 19 countries achieved a turnover of over one billion Swiss francs. Already today, around 70 percent of the operating profit comes from the digital business, making Ringier a leading European media company. Ringier stands for pioneering spirit, independence and freedom of opinion.
About Brightcove Inc. (NASDAQ: BCOV)
We are the people behind the world’s leading video technology platform. With our award-winning technology and services, we help organizations in more than 70 countries meet business challenges and create strategic opportunities by inspiring, entertaining, and engaging their audiences through video.
Since Brightcove was established in 2004, we have consistently pushed boundaries to create a platform for people who are serious about video: one that is robust, scalable, and intuitive. Benefiting from a global infrastructure, unrivalled customer support, an extensive partner ecosystem, and relentless investment in R&D, Brightcove video sets the standard for professional grade video management, distribution, and monetization. To learn more, visit www.brightcove.com.
Senior Public Relations Manager
Brightcove | 603-785-8518
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Data from the APOLLO Study Show Clinically Meaningful Response with DARZALEX ® ▼ (daratumumab) Subcutaneous Formulation Regimen After First or Subsequent Relapse in Multiple Myeloma4.12.2020 20:52:00 CET | Press release
The Janssen Pharmaceutical Companies of Johnson & Johnson announced results of the Phase 3 APOLLO study showing that the addition of DARZALEX®▼ (daratumumab) subcutaneous (SC) formulation to pomalidomide and dexamethasone (D-Pd) significantly reduced the risk of progression or death by 37 percent, compared to Pd alone in patients with multiple myeloma (MM) after the first or subsequent relapse of disease.1 The APOLLO results, which will be presented on Sunday, December 6 at 9:00 p.m. CET during the American Society of Hematology (ASH) 2020 Annual Meeting and featured in the ASH press briefing (Abstract #112), add to the body of evidence supporting treatment with daratumumab SC-based regimens for patients with relapsed MM. These data were the basis for recent regulatory submissions in Europe and the United States (U.S.) seeking approval for daratumumab SC in combination with Pd for the treatment of patients with relapsed or refractory MM, with two or more prior lines of therapy, includi
Citi Private Bank Issues Outlook 2021: The New Economic Cycle: Investing for a Post-COVID World4.12.2020 17:36:00 CET | Press release
Citi Private Bank has released its Outlook 2021: The New Economic Cycle: Investing for a Post-COVID World. The twice-yearly publication provides in-depth insights into the global economy and financial markets for the coming year and highlights multi-year “unstoppable trends” for client portfolios. This edition outlines why this is a remarkable time to be an investor. Just as the pandemic changed the price of every security when it arrived, the departure of COVID will mark the beginning of a new economic cycle, creating new opportunities for investors. Citi Private Bank expects 2021 will benefit from an economy that demonstrated resilience in the face of the worst global healthcare crisis in more than a century. 2020 was an opportunity for the world to “test drive the future” and make way for growth as the pandemic ebbs. The tailwinds for 2021 are underappreciated: our financial system is strong, government actions to protect individuals and businesses have been effective, technological
Takashi Nagao Appointed President and Chief Executive Officer of Medicago4.12.2020 17:00:00 CET | Press release
Medicago, a biopharmaceutical company headquartered in Quebec City, Canada, today announced Takashi Nagao as the company’s new President and Chief Executive Officer. Prior to becoming President and CEO, Mr. Nagao served as the Chairman of the Board of Medicago, where for the last four years, he has guided Medicago executives to get the company to where it is today. Medicago, a research and development company for the last 20 years, is embarking on a transformative year, one that will see the company build on its R&D roots to become a company that also produces and commercializes vaccines and other immunotherapies. Mr. Nagao has extensive experience leading pharmaceutical companies through the pre-commercial and commercial process and is well positioned to ensure the successful launch of Medicago’s COVID-19 and influenza vaccines, subject to regulatory approvals. Mr. Nagao will continue Medicago’s evolution towards its goal of being a fully operational commercial entity, able to respond
WorldRemit Leads the Way Offering a USD Payout Option in Nigeria4.12.2020 16:46:00 CET | Press release
WorldRemit, a leading digital cross-border payments business has announced that its customers in Nigeria can now receive remittances in foreign currency (USD) through its cash pick up providers. Following the announcement of the Central Bank of Nigeria (CBN) a day before, WorldRemit quickly adapted to the new requirements making it the first digital service to offer its customers worldwide the option of cash pickup in USD in Nigeria. WorldRemit enables Nigerians in over 50 countries around the world to support their family and friends in Nigeria. The decision by the Central Bank of Nigeria (CBN) to allow international money transfers to be paid in foreign currency, is aimed at providing increased liquidity in the foreign exchange market. The bank explained that the new regulation is part of its efforts to liberalize, simplify and improve the receipt and administration of diaspora remittances into Nigeria. Gbenga Okejimi, Country Manager, Nigeria and Ghana, at WorldRemit, said:“ We are
PPC Upgraded to ‘B’ with ‘Stable’ Outlook by S&P4.12.2020 15:16:00 CET | Press release
In its annual research update released on 27 November 2020, S&P upgraded PPC’s stand-alone credit profile (SACP) upward by two notches to ‘B’ from ‘CCC+’, resulting in an overall upgrade of the long-term credit rating of PPC to ‘B’ from ‘B-‘. According to S&P the two notch upgrade in PPC’s standalone corporate rating confirms that the Company’s strategic repositioning and the improved Greek energy market fundamentals have transformed its competitive position, reducing past concerns over its liquidity and long-term sustainability. The ‘Stable’ outlook underscores S&P’s expectation that PPC will continue to deliver on its transformation plan, with solid liquidity and improved margins. PPC’s strategic plan to convert its generation mix toward lower carbon dioxide (CO2) emissions improve its fleet competitiveness and long-term prospects. As mentioned in their report, S&P expects a substantial increase in EBITDA and improvement in credit metrics on the back of higher profitability as PPC ac
Chengdu Launches Online Exhibition of History and Culture to Enhance Cultural Ties With European Countries4.12.2020 13:17:00 CET | Press release
The launching ceremony of Chengdu History and Culture Overseas Virtual Exhibition was held by the Chengdu Chronicles Compilation Committee at Chengdu Chronicles Office on 24 November. The event, along with the unveiling ceremony of Chengdu Chronicles Culture Overseas (Europe) Exchange Cooperation, were witnessed by distinguished guests in many European countries including the Netherlands, Germany and Belgium through video and online connections. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201204005278/en/ On November 24, Gao Zhigang (center), Director of Chengdu Chronicles Compilation Committee at Chengdu Chronicles Office, and other guests attend the launching ceremony of Chengdu History and Culture Overseas Virtual Exhibition. (Photo: Business Wire) Chengdu History and Culture Overseas Virtual Exhibition will also be launched at major foreign media platforms for audiences all over the world. Gao ZhiGang, Director of Che
New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint4.12.2020 12:00:00 CET | Press release
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-620 (maribavir), in the treatment of transplant recipients with refractory/resistant cytomegalovirus (CMV) infection. The TAK-620-303 (SOLSTICE) trial (NCT02931539) is a multicenter, randomized, open-label, active-controlled trial comparing eight weeks of treatment with either maribavir or investigator assigned treatment (IAT) in transplant recipients with CMV infection refractory or resistant to existing antiviral treatments (i.e., one or a combination of ganciclovir, valganciclovir, foscarnet or cidofovir). The SOLSTICE trial met its primary endpoint, defined as the proportion of patients who achieved confirmed CMV viremia clearance compared to IAT at the end of Study week 8. In addition, the SOLSTICE trial met its key secondary endpoint, defined as achievement of CMV viremia clearance
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom